🧪 Hypotheses

211 hypotheses generated by SciDEX — searchable by gene, disease, or keyword

211
Total Hypotheses
190
Validated
0.66
Avg Score
0.56
Avg Feasibility

Validated Hypotheses

190 hypotheses have passed validation gates and now form the scientific closure set.

API
All therapeutic (211)mechanistic (0)diagnostic (0)methodological (0)
Sort: ScoreFeasibilityNoveltyImpactNewest
therapeutic 0.00
Closed-loop transcranial focused ultrasound with gamma entrainment to restore hippocampal-cortical synchrony via PV inte
🧬 PVALB 🏥 alzheimers 📖 65🏛 3
✅ 0.00 ✨ 0.00 💥 0.00
This hypothesis combines the precision of transcranial focused ultrasound (tFUS) targeting with gamma entrainment therapy to restore hippocampal-corti...
therapeutic 0.00
Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via SST interneuron disinhibition
🧬 SST 🏥 alzheimers 📖 65🏛 3
✅ 0.00 ✨ 0.00 💥 0.00
This intervention targets somatostatin-positive (SST) interneurons in the stratum oriens to restore hippocampal gamma oscillations through disinhibiti...
therapeutic 0.00
Alpha-theta entrainment therapy to enhance default mode network coherence
🧬 SST 🏥 alzheimers 📖 57🏛 2
✅ 0.00 ✨ 0.00 💥 0.00
Alpha-theta entrainment therapy targets somatostatin (SST) interneurons to restore default mode network (DMN) coherence in Alzheimer's disease through...
therapeutic 0.97
Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal gamma oscillations v
🧬 SST 🏥 alzheimers 📖 55🏛 3
✅ 0.00 ✨ 0.60 💥 0.00
## Mechanistic Overview...
therapeutic 0.96
Closed-loop optogenetic targeting PV interneurons to restore theta-gamma coupling and prevent amyloid-induced synaptic d
🧬 PVALB 🏥 alzheimers 📖 61🏛 3
✅ 0.00 ✨ 0.50 💥 0.00
## Mechanistic Overview...
therapeutic 0.96
Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to prevent tau propagation and restore ento
🧬 SST 🏥 alzheimers 📖 50🏛 3
✅ 0.54 ✨ 0.85 💥 0.74
## Mechanistic Overview...
therapeutic 0.95
Gamma entrainment therapy to restore hippocampal-cortical synchrony
🧬 SST 🏥 alzheimers 📖 66🏛 2
✅ 0.88 ✨ 0.78 💥 0.80
## Mechanistic Overview...
therapeutic 0.91
Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via cholecystokinin interneuron ne
🧬 CCK 🏥 alzheimers 📖 61🏛 2
✅ 0.00 ✨ 0.64 💥 0.00
## Mechanistic Overview...
therapeutic 0.89
APOE-Dependent Autophagy Restoration
🧬 MTOR 🏥 neurodegeneration 📖 56🏛 3
✅ 0.90 ✨ 0.60 💥 0.80
## Mechanistic Overview...
therapeutic 0.89
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization
🧬 BDNF 🏥 alzheimers 📖 11🏛 3
✅ 0.70 ✨ 0.82 💥 0.83
## Mechanistic Overview...
therapeutic 0.88
Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance
🧬 SST 🏥 alzheimers 📖 57🏛 2
✅ 0.85 ✨ 0.82 💥 0.82
## Mechanistic Overview...
therapeutic 0.88
Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation
🧬 HCRTR1/HCRTR2 🏥 neurodegeneration 📖 37🏛 2
✅ 0.90 ✨ 0.75 💥 0.80
## Mechanistic Overview...
therapeutic 0.87
Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block tau AIS disruption i
🧬 PVALB 🏥 alzheimers 📖 64🏛 2
✅ 0.86 ✨ 0.79 💥 0.80
## Mechanistic Overview...
therapeutic 0.87
Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct PV interneuron recruitm
🧬 PVALB 🏥 alzheimers 📖 68🏛 3
✅ 0.82 ✨ 0.78 💥 0.75
## Mechanistic Overview...
therapeutic 0.87
Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activation using implantable LED
🧬 PVALB 🏥 alzheimers 📖 68🏛 3
✅ 0.45 ✨ 0.78 💥 0.68
## Mechanistic Overview...
therapeutic 0.86
Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling and prevent tau seeding i
🧬 PVALB 🏥 alzheimers 📖 67🏛 3
✅ 0.45 ✨ 0.85 💥 0.75
## Mechanistic Overview...
therapeutic 0.85
Senescent Cell ASM-Complement Cascade Intervention
🧬 SMPD1 🏥 neurodegeneration 📖 54🏛 1
✅ 0.68 ✨ 0.78 💥 0.75
## Mechanistic Overview...
therapeutic 0.84
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration
🧬 SMPD3 🏥 neurodegeneration 📖 45🏛 1
✅ 0.68 ✨ 0.78 💥 0.75
## Mechanistic Overview...
therapeutic 0.83
AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses
🧬 PRKAA1 🏥 neurodegeneration 📖 45🏛 2
✅ 0.85 ✨ 0.80 💥 0.75
## Mechanistic Overview...
therapeutic 0.83
Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amy
🧬 PVALB 🏥 alzheimers 📖 65🏛 2
✅ 0.55 ✨ 0.82 💥 0.78
## Mechanistic Overview...
therapeutic 0.83
Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal-prefronta
🧬 SST 🏥 alzheimers 📖 50🏛 3
✅ 0.35 ✨ 0.82 💥 0.78
## Mechanistic Overview...
therapeutic 0.82
miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy
🧬 miR-33/ABCA1 🏥 molecular-biology 📖 8🏛 1
✅ 0.51 ✨ 0.70 💥 0.65
## Mechanistic Overview...
therapeutic 0.82
Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation
🧬 BDNF 🏥 alzheimers 📖 77🏛 2
✅ 0.72 ✨ 0.68 💥 0.78
## Mechanistic Overview...
therapeutic 0.82
CYP46A1 Small Molecule Activator Therapy
🧬 CYP46A1 🏥 neurodegeneration 📖 47🏛 3
✅ 0.75 ✨ 0.71 💥 0.76
This approach employs pharmacological activation of endogenous CYP46A1 rather than gene overexpression to treat Alzheimer's disease through enhanced b...
therapeutic 0.82
CYP46A1-Mediated Cholesterol Reduction Prevents eIF2α-Driven Translation Stalling in Neurodegeneration
🧬 CYP46A1 🏥 neurodegeneration 📖 47🏛 3
✅ 0.75 ✨ 0.71 💥 0.76
This hypothesis proposes that CYP46A1 overexpression gene therapy prevents neurodegeneration by disrupting the pathological link between cholesterol d...
therapeutic 0.81
Extracellular Vesicle Biogenesis Modulation
🧬 CHMP4B 🏥 neurodegeneration 📖 29🏛 1
✅ 0.35 ✨ 0.63 💥 0.00
## Mechanistic Overview...
therapeutic 0.81
Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagation via perforant path i
🧬 PVALB 🏥 alzheimers 📖 58🏛 3
✅ 0.78 ✨ 0.76 💥 0.75
## Mechanistic Overview...
therapeutic 0.81
LRP1-Dependent Tau Uptake Disruption
🧬 LRP1 🏥 neurodegeneration 📖 23🏛 1
✅ 0.29 ✨ 0.35 💥 0.00
## Mechanistic Overview...
therapeutic 0.81
Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neuroinflammation
🧬 HCAR2 🏥 neurodegeneration 📖 11🏛 1
✅ 0.82 ✨ 0.70 💥 0.75
## Mechanistic Overview...
therapeutic 0.81
Neutrophil Extracellular Trap (NET) Inhibition
🧬 PADI4 🏥 N/A 📖 10🏛 1
✅ 0.00 ✨ 0.41 💥 0.00
## Mechanistic Overview...
Loading more hypotheses...